US5855908A
(en)
*
|
1984-05-01 |
1999-01-05 |
University Of Utah Research Foundation |
Non-dissolvable drug-containing dosage-forms for use in the transmucosal delivery of a drug to a patient
|
US4863737A
(en)
*
|
1985-05-01 |
1989-09-05 |
University Of Utah |
Compositions and methods of manufacture of compressed powder medicaments
|
US4573995A
(en)
*
|
1984-10-09 |
1986-03-04 |
Alza Corporation |
Transdermal therapeutic systems for the administration of naloxone, naltrexone and nalbuphine
|
US4655767A
(en)
*
|
1984-10-29 |
1987-04-07 |
Dow Corning Corporation |
Transdermal drug delivery devices with amine-resistant silicone adhesives
|
US4751087A
(en)
*
|
1985-04-19 |
1988-06-14 |
Riker Laboratories, Inc. |
Transdermal nitroglycerin delivery system
|
US4885173A
(en)
*
|
1985-05-01 |
1989-12-05 |
University Of Utah |
Methods and compositions for noninvasive dose-to-effect administration of drugs with cardiovascular or renal vascular activities
|
US5122127A
(en)
*
|
1985-05-01 |
1992-06-16 |
University Of Utah |
Apparatus and methods for use in administering medicaments by direct medicament contact to mucosal tissues
|
US5132114A
(en)
*
|
1985-05-01 |
1992-07-21 |
University Of Utah Research Foundation |
Compositions and methods of manufacture of compressed powder medicaments
|
US4671953A
(en)
*
|
1985-05-01 |
1987-06-09 |
University Of Utah Research Foundation |
Methods and compositions for noninvasive administration of sedatives, analgesics, and anesthetics
|
US5288497A
(en)
*
|
1985-05-01 |
1994-02-22 |
The University Of Utah |
Compositions of oral dissolvable medicaments
|
US4645502A
(en)
*
|
1985-05-03 |
1987-02-24 |
Alza Corporation |
Transdermal delivery of highly ionized fat insoluble drugs
|
DE3682165D1
(de)
*
|
1985-11-08 |
1991-11-28 |
Nitto Denko Corp |
Verwendung von heftpflastern fuer die haut und perkutanen praeparaten.
|
US4666441A
(en)
*
|
1985-12-17 |
1987-05-19 |
Ciba-Geigy Corporation |
Multicompartmentalized transdermal patches
|
EP0249343B1
(fr)
*
|
1986-06-13 |
1992-01-08 |
Alza Corporation |
Activation par l'humidité d'un système à libération transdermale des drogues
|
US4908027A
(en)
*
|
1986-09-12 |
1990-03-13 |
Alza Corporation |
Subsaturated transdermal therapeutic system having improved release characteristics
|
US5344656A
(en)
*
|
1986-09-12 |
1994-09-06 |
Alza Corporation |
Subsaturated transdermal therapeutic system having improved release characteristics
|
US4863970A
(en)
*
|
1986-11-14 |
1989-09-05 |
Theratech, Inc. |
Penetration enhancement with binary system of oleic acid, oleins, and oleyl alcohol with lower alcohols
|
AU601528B2
(en)
*
|
1986-12-22 |
1990-09-13 |
Ortho-Mcneil Pharmaceutical, Inc. |
Resilient transdermal drug-delivery device and compositions and devices employing fatty acid esters/ethers of alkanediols and percutaneous absorption enhancers
|
US4906463A
(en)
*
|
1986-12-22 |
1990-03-06 |
Cygnus Research Corporation |
Transdermal drug-delivery composition
|
US5006342A
(en)
*
|
1986-12-22 |
1991-04-09 |
Cygnus Corporation |
Resilient transdermal drug delivery device
|
AU607172B2
(en)
*
|
1986-12-22 |
1991-02-28 |
Cygnus, Inc. |
Diffusion matrix for transdermal drug administration
|
US4822802A
(en)
*
|
1987-02-24 |
1989-04-18 |
Alza Corporation |
Method of fentanly administration for postoperative pain relief
|
US5071656A
(en)
*
|
1987-03-05 |
1991-12-10 |
Alza Corporation |
Delayed onset transdermal delivery device
|
US5080646A
(en)
*
|
1988-10-03 |
1992-01-14 |
Alza Corporation |
Membrane for electrotransport transdermal drug delivery
|
US5186939A
(en)
*
|
1987-04-23 |
1993-02-16 |
Cygnus Therapeutic Systems |
Laminated composite for transdermal administration of fentanyl
|
US4981782A
(en)
*
|
1987-05-14 |
1991-01-01 |
Sri International |
Synthetic peptides for diagnosis and prevention of influenza virus infection and their use
|
US4853227A
(en)
*
|
1987-10-23 |
1989-08-01 |
Ciba-Geigy Corporation |
Transdermal administration of a systemic active agent to a premature neonatal infant
|
US4781924A
(en)
|
1987-11-09 |
1988-11-01 |
Alza Corporation |
Transdermal drug delivery device
|
US4863738A
(en)
*
|
1987-11-23 |
1989-09-05 |
Alza Corporation |
Skin permeation enhancer compositions using glycerol monooleate
|
US5064654A
(en)
*
|
1989-01-11 |
1991-11-12 |
Ciba-Geigy Corporation |
Mixed solvent mutually enhanced transdermal therapeutic system
|
US5925372A
(en)
*
|
1987-12-16 |
1999-07-20 |
Novartis Corporation |
Mixed solvent mutually enhanced transdermal therapeutic system
|
US4915950A
(en)
*
|
1988-02-12 |
1990-04-10 |
Cygnus Research Corporation |
Printed transdermal drug delivery device
|
US5223261A
(en)
*
|
1988-02-26 |
1993-06-29 |
Riker Laboratories, Inc. |
Transdermal estradiol delivery system
|
US5004610A
(en)
*
|
1988-06-14 |
1991-04-02 |
Alza Corporation |
Subsaturated nicotine transdermal therapeutic system
|
US5169382A
(en)
*
|
1988-10-03 |
1992-12-08 |
Alza Corporation |
Membrane for electrotransport transdermal drug delivery
|
US5236714A
(en)
*
|
1988-11-01 |
1993-08-17 |
Alza Corporation |
Abusable substance dosage form having reduced abuse potential
|
US4891377A
(en)
*
|
1988-12-02 |
1990-01-02 |
Board Of Regents Acting For And On Behalf Of University Of Michigan |
Transdermal delivery of the narcotic analgesics etorphine and analogs
|
US5332577A
(en)
*
|
1988-12-27 |
1994-07-26 |
Dermamed |
Transdermal administration to humans and animals
|
US5241925A
(en)
*
|
1988-12-27 |
1993-09-07 |
Dermamed |
Apparatus and techniques for administering veterinary medicaments
|
US5139023A
(en)
*
|
1989-06-02 |
1992-08-18 |
Theratech Inc. |
Apparatus and method for noninvasive blood glucose monitoring
|
US4956171A
(en)
*
|
1989-07-21 |
1990-09-11 |
Paco Pharmaceutical Services, Inc. |
Transdermal drug delivery using a dual permeation enhancer and method of performing the same
|
US5512292A
(en)
*
|
1990-10-29 |
1996-04-30 |
Alza Corporation |
Transdermal contraceptive formulations methods and devices
|
US5149538A
(en)
*
|
1991-06-14 |
1992-09-22 |
Warner-Lambert Company |
Misuse-resistive transdermal opioid dosage form
|
WO1993007870A1
(fr)
*
|
1991-10-18 |
1993-04-29 |
Alza Corporation |
Dispositif pour l'administration transdermique de melatonine
|
US5268179A
(en)
*
|
1992-02-14 |
1993-12-07 |
Ciba-Geigy Corporation |
Ultrasonically sealed transdermal drug delivery systems
|
US5900250A
(en)
*
|
1992-05-13 |
1999-05-04 |
Alza Corporation |
Monoglyceride/lactate ester permeation enhancer for oxybutnin
|
ZA933349B
(en)
*
|
1992-05-13 |
1994-06-15 |
Alza Corp |
Transdermal administration of oxybutynin
|
US5607691A
(en)
*
|
1992-06-12 |
1997-03-04 |
Affymax Technologies N.V. |
Compositions and methods for enhanced drug delivery
|
US5591767A
(en)
*
|
1993-01-25 |
1997-01-07 |
Pharmetrix Corporation |
Liquid reservoir transdermal patch for the administration of ketorolac
|
US5451407A
(en)
*
|
1993-06-21 |
1995-09-19 |
Alza Corporation |
Reduction or prevention of skin irritation or sensitization during transdermal administration of a irritating or sensitizing drug
|
US5919478A
(en)
*
|
1993-06-25 |
1999-07-06 |
Alza Corporation |
Incorporating poly-N-vinyl amide in a transdermal system
|
US5750137A
(en)
*
|
1993-09-29 |
1998-05-12 |
Taskovich; Lina Tormen |
Monoglyceride/lactate ester permeation enhancer
|
US5635204A
(en)
*
|
1994-03-04 |
1997-06-03 |
Montefiore Medical Center |
Method for transdermal induction of anesthesia, analgesia or sedation
|
US7027859B1
(en)
*
|
1994-09-26 |
2006-04-11 |
Alza Corporation |
Electrotransport delivery device having improved safety and reduced abuse potential
|
WO1996015826A1
(fr)
|
1994-11-17 |
1996-05-30 |
Alza Corporation |
Composition et procede pour ameliorer l'administration d'un agent par electrotransport
|
US5843014A
(en)
*
|
1995-03-24 |
1998-12-01 |
Alza Corporation |
Display for an electrotransport delivery device
|
US5879322A
(en)
*
|
1995-03-24 |
1999-03-09 |
Alza Corporation |
Self-contained transdermal drug delivery device
|
IE960375A1
(en)
*
|
1995-06-05 |
1996-12-11 |
Alza Corp |
Device for transdermal electrotransport delivery of fentanyl¹and sufentanil
|
US6881208B1
(en)
*
|
1995-06-05 |
2005-04-19 |
Joseph B. Phipps |
Method and device for transdermal electrotransport delivery of fentanyl and sufentanil
|
US6216033B1
(en)
|
1996-05-22 |
2001-04-10 |
Alza Corporation |
Device for transdermal electrotransport delivery of fentanyl and sufentanil
|
US6425892B2
(en)
|
1995-06-05 |
2002-07-30 |
Alza Corporation |
Device for transdermal electrotransport delivery of fentanyl and sufentanil
|
US6572879B1
(en)
|
1995-06-07 |
2003-06-03 |
Alza Corporation |
Formulations for transdermal delivery of pergolide
|
US5785991A
(en)
*
|
1995-06-07 |
1998-07-28 |
Alza Corporation |
Skin permeation enhancer compositions comprising glycerol monolaurate and lauryl acetate
|
US6245347B1
(en)
*
|
1995-07-28 |
2001-06-12 |
Zars, Inc. |
Methods and apparatus for improved administration of pharmaceutically active compounds
|
US5840327A
(en)
*
|
1995-08-21 |
1998-11-24 |
Alza Corporation |
Transdermal drug delivery device having enhanced adhesion
|
US5667799A
(en)
*
|
1995-10-30 |
1997-09-16 |
Caldwell; Larry J. |
Method for treating headache pain with topical local anesthetic compositions
|
US5730721A
(en)
*
|
1996-01-25 |
1998-03-24 |
Vesture Corporation |
Medical applicator and method
|
US6007837A
(en)
*
|
1996-07-03 |
1999-12-28 |
Alza Corporation |
Drug delivery devices and process of manufacture
|
US6512010B1
(en)
|
1996-07-15 |
2003-01-28 |
Alza Corporation |
Formulations for the administration of fluoxetine
|
US6203817B1
(en)
|
1997-02-19 |
2001-03-20 |
Alza Corporation |
Reduction of skin reactions caused by transdermal drug delivery
|
US5968547A
(en)
*
|
1997-02-24 |
1999-10-19 |
Euro-Celtique, S.A. |
Method of providing sustained analgesia with buprenorphine
|
US6174545B1
(en)
|
1997-07-01 |
2001-01-16 |
Alza Corporation |
Drug delivery devices and process of manufacture
|
US6660295B2
(en)
|
1997-09-30 |
2003-12-09 |
Alza Corporation |
Transdermal drug delivery device package with improved drug stability
|
US6918901B1
(en)
*
|
1997-12-10 |
2005-07-19 |
Felix Theeuwes |
Device and method for enhancing transdermal agent flux
|
US6050988A
(en)
*
|
1997-12-11 |
2000-04-18 |
Alza Corporation |
Device for enhancing transdermal agent flux
|
KR100561892B1
(ko)
*
|
1997-12-11 |
2006-03-16 |
알자 코포레이션 |
경피성 작용제 유동률을 증진시키기 위한 장치
|
EP1911488A3
(fr)
|
1997-12-11 |
2008-12-03 |
Alza Corporation |
Dispositif pour améliorer le flux d'agent transdermique
|
CN1206004C
(zh)
|
1997-12-11 |
2005-06-15 |
阿尔扎有限公司 |
增强透皮物剂流量的装置
|
ES2182379T3
(es)
*
|
1997-12-22 |
2003-03-01 |
Alza Corp |
Membrana de regulacion del regimen de liberacion para dispositivos de administracion controlada de farmacos.
|
US6103771A
(en)
*
|
1998-03-20 |
2000-08-15 |
Caldwell Galer Incorporated |
Method of treating neuroma pain
|
US6699497B1
(en)
|
1998-07-24 |
2004-03-02 |
Alza Corporation |
Formulations for the transdermal administration of fenoldopam
|
US6858018B1
(en)
|
1998-09-28 |
2005-02-22 |
Vyteris, Inc. |
Iontophoretic devices
|
US6348210B1
(en)
|
1998-11-13 |
2002-02-19 |
Alza Corporation |
Methods for transdermal drug administration
|
PT1140039E
(pt)
*
|
1998-12-18 |
2010-02-03 |
Alza Corp |
Dispositivos transparentes de administração transdérmica de nicotina
|
GB9828480D0
(en)
*
|
1998-12-24 |
1999-02-17 |
Dermatech Limited |
Transdermal drug delivery system
|
US20070196490A1
(en)
*
|
1999-01-22 |
2007-08-23 |
Powderject Research Limited |
Method of enhancing needleless transdermal powered drug delivery
|
US6541021B1
(en)
*
|
1999-03-18 |
2003-04-01 |
Durect Corporation |
Devices and methods for pain management
|
US6835194B2
(en)
*
|
1999-03-18 |
2004-12-28 |
Durect Corporation |
Implantable devices and methods for treatment of pain by delivery of fentanyl and fentanyl congeners
|
JP5031144B2
(ja)
*
|
1999-03-25 |
2012-09-19 |
メタボリックス,インコーポレイテッド |
ポリヒドロキシアルカノエートポリマーの医療デバイスおよび医療適用
|
EP1169025B1
(fr)
*
|
1999-04-01 |
2005-08-24 |
Alza Corporation |
Dispositifs d'administration transdermale de medicaments comprenant un reservoir de medicament en polyurethane
|
JP2003508425A
(ja)
|
1999-08-30 |
2003-03-04 |
テファ, インコーポレイテッド |
洗浄可能な使い捨てポリマー製品
|
KR20010036685A
(ko)
|
1999-10-11 |
2001-05-07 |
김윤 |
펜타닐을 함유하는 매트릭스형 경피투여제
|
WO2001041863A1
(fr)
|
1999-12-10 |
2001-06-14 |
Alza Corporation |
Dispositif et procede d'amelioration de percage de peau par micro-protuberances
|
ATE405264T1
(de)
|
2000-02-08 |
2008-09-15 |
Euro Celtique Sa |
Zusammensetzungen mit kontrollierter freisetzung, die einen opioid agonist und antagonist enthalten
|
JP4969009B2
(ja)
*
|
2000-03-10 |
2012-07-04 |
ダレクト コーポレーション |
オピオイド製剤
|
US7074803B2
(en)
*
|
2001-03-02 |
2006-07-11 |
Durect Corporation |
Opioid formulations
|
US7179483B2
(en)
|
2000-04-26 |
2007-02-20 |
Watson Pharmaceuticals, Inc. |
Compositions and methods for transdermal oxybutynin therapy
|
DK1642578T3
(da)
*
|
2000-07-31 |
2013-08-12 |
Takeda Pharma As |
Fentanyl salt-sammensætning til nasal administration
|
EP1318843B1
(fr)
*
|
2000-09-19 |
2013-04-17 |
Henkel AG & Co. KGaA |
Adhesif non reactif, utile dans des systemes d'apport transdermique de medicaments
|
US20020119187A1
(en)
*
|
2000-09-29 |
2002-08-29 |
Cantor Adam S. |
Composition for the transdermal delivery of fentanyl
|
DE60220661T2
(de)
*
|
2001-03-16 |
2008-02-14 |
Alza Corp., Mountain View |
Transdermales pflaster zur verabreichung von fentanyl
|
US20050208117A1
(en)
*
|
2001-03-16 |
2005-09-22 |
Venkatraman Subramanian S |
Transdermal administration of fentanyl and analogs thereof
|
EP1757280A1
(fr)
|
2001-03-16 |
2007-02-28 |
ALZA Corporation |
Timbre transdermique pour l'administration de sufentanyle
|
US8329734B2
(en)
|
2009-07-27 |
2012-12-11 |
Afgin Pharma Llc |
Topical therapy for migraine
|
ATE404193T1
(de)
*
|
2001-06-05 |
2008-08-15 |
Ronald Aung-Din |
Topische migränetherapie
|
DE10141651B4
(de)
|
2001-08-24 |
2007-02-15 |
Lts Lohmann Therapie-Systeme Ag |
Transdermales Therapeutisches System (TTS) mit dem Wirkstoff Fentanyl und Verfahren zu seiner Herstellung
|
US20030068375A1
(en)
|
2001-08-06 |
2003-04-10 |
Curtis Wright |
Pharmaceutical formulation containing gelling agent
|
US7247315B2
(en)
*
|
2001-08-17 |
2007-07-24 |
Lavipharm Laboratories Inc. |
Compositions and medical device for transdermal delivery of a drug and methods of making and using same
|
DE10141650C1
(de)
*
|
2001-08-24 |
2002-11-28 |
Lohmann Therapie Syst Lts |
Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen
|
KR100844312B1
(ko)
*
|
2001-09-06 |
2008-07-07 |
노사케미컬(주) |
펜타닐 경피 투여 제제
|
NZ535971A
(en)
*
|
2002-04-23 |
2007-07-27 |
Alza Corp |
Transdermal analgesic patch with reduced abuse potential
|
GB0210397D0
(en)
*
|
2002-05-07 |
2002-06-12 |
Ferring Bv |
Pharmaceutical formulations
|
DE10223835A1
(de)
|
2002-05-28 |
2003-12-11 |
Labtec Gmbh |
Pflaster, enthaltend Fentanylum
|
CN1655772B
(zh)
*
|
2002-05-28 |
2010-05-26 |
拉伯泰克技术研发有限公司 |
含有芬太尼的贴剂
|
US7157102B1
(en)
|
2002-05-31 |
2007-01-02 |
Biotek, Inc. |
Multi-layered microcapsules and method of preparing same
|
US7041320B1
(en)
|
2002-05-31 |
2006-05-09 |
Biotek, Inc. |
High drug loaded injectable microparticle compositions and methods of treating opioid drug dependence
|
AU2003251482A1
(en)
*
|
2002-06-10 |
2003-12-22 |
Euro-Celtique, S.A. |
Disposal systems of transdermal delivery devices to prevent misuse of the active agents contained therein
|
US8246979B2
(en)
|
2002-07-30 |
2012-08-21 |
Ucb Pharma Gmbh |
Transdermal delivery system for the administration of rotigotine
|
US8246980B2
(en)
*
|
2002-07-30 |
2012-08-21 |
Ucb Pharma Gmbh |
Transdermal delivery system
|
AU2003268376A1
(en)
*
|
2002-08-30 |
2004-11-26 |
Watson Pharmaceuticals, Inc. |
Transdermal delivery systems and methods
|
AU2003272878A1
(en)
*
|
2002-09-13 |
2004-04-30 |
Hisamitsu Pharmaceutical Co., Inc. |
Adhesive patch
|
CN1703200B
(zh)
|
2002-09-20 |
2012-02-29 |
奥尔制药公司 |
隔离亚单元和相关组合物及方法
|
TWI296531B
(en)
*
|
2002-10-18 |
2008-05-11 |
Hisamitsu Pharmaceutical Co |
Transdermal adhesive preparations for topical administration of fentanyl
|
ATE444296T1
(de)
*
|
2002-10-25 |
2009-10-15 |
Euro Celtique Sa |
Analoga und prodrugs von buprenorphin
|
US20040086551A1
(en)
*
|
2002-10-30 |
2004-05-06 |
Miller Kenneth J. |
Fentanyl suspension-based silicone adhesive formulations and devices for transdermal delivery of fentanyl
|
US20040102476A1
(en)
*
|
2002-11-25 |
2004-05-27 |
Chan Tai Wah |
High concentration formulations of opioids and opioid derivatives
|
PL378076A1
(pl)
*
|
2003-02-07 |
2006-02-20 |
Lts Lohmann Therapie-Systeme Ag |
Transdermalny system terapeutyczny nadający się do użycia ciepła w celu przyspieszenia przenikania substancji czynnych i jego zastosowanie
|
US20060062812A1
(en)
*
|
2003-03-11 |
2006-03-23 |
Calvin Ross |
Novel compositions
|
US20040191301A1
(en)
*
|
2003-03-27 |
2004-09-30 |
Van Duren Albert Philip |
Transdermal device having a phase change material
|
US20040258742A1
(en)
*
|
2003-04-11 |
2004-12-23 |
Van Osdol William Woodson |
Transdermal administration of N-(2,5-disubstituted phenyl)-N'-(3-substituted phenyl)-N'-methyl guanidines
|
US7834147B2
(en)
*
|
2003-04-28 |
2010-11-16 |
Childrens Hospital Medical Center |
Saposin C-DOPS: a novel anti-tumor agent
|
AU2004235794B8
(en)
*
|
2003-04-30 |
2009-07-23 |
Purdue Pharma L.P. |
Tamper-resistant transdermal dosage form comprising an active agent component and an adverse agent component at the distal site of the active agent layer
|
US8790689B2
(en)
|
2003-04-30 |
2014-07-29 |
Purdue Pharma L.P. |
Tamper resistant transdermal dosage form
|
US8034270B2
(en)
|
2003-05-08 |
2011-10-11 |
Tepha, Inc. |
Polyhydroxyalkanoate medical textiles and fibers
|
JP5137286B2
(ja)
|
2003-06-10 |
2013-02-06 |
帝國製薬株式会社 |
フェンタニル含有口腔粘膜貼付剤
|
WO2004112723A2
(fr)
*
|
2003-06-20 |
2004-12-29 |
Ronald Aung-Din |
Therapie locale pour le traitement des migraines, des claquages musculaires, des spasmes musculaires, de la spasticite et d'etats apparentes
|
CA2531833C
(fr)
*
|
2003-07-08 |
2009-10-20 |
Tepha, Inc. |
Matrices poly-4-hydroxybutyrate pour une administration prolongee de medicaments
|
US8524272B2
(en)
|
2003-08-15 |
2013-09-03 |
Mylan Technologies, Inc. |
Transdermal patch incorporating active agent migration barrier layer
|
CA2536510C
(fr)
*
|
2003-08-22 |
2011-01-18 |
Tepha, Inc. |
Dispositifs de regeneration nerveuse a base de polyhydroxyalkanoate
|
CN1909892A
(zh)
*
|
2003-10-30 |
2007-02-07 |
阿尔扎公司 |
具有降低的滥用可能性的透皮止痛剂***
|
US7105263B2
(en)
*
|
2003-12-30 |
2006-09-12 |
Samsung Electronics Company |
Dry toner comprising encapsulated pigment, methods and uses
|
US7867511B2
(en)
|
2004-01-23 |
2011-01-11 |
Travanti Pharma Inc. |
Abuse potential reduction in abusable substance dosage form
|
US8535711B2
(en)
*
|
2004-01-23 |
2013-09-17 |
Teikoku Pharma Usa, Inc. |
Medication disposal system
|
ME02661B
(fr)
|
2004-02-23 |
2017-06-20 |
Euro Celtique Sa |
Dispositif d'administration transdermique opioïde résistante aux abus
|
WO2005105009A1
(fr)
*
|
2004-04-26 |
2005-11-10 |
Cassel Douglas R |
Timbre pour traitement des plaies apaisant la douleur
|
ES2653568T3
(es)
|
2004-06-12 |
2018-02-07 |
Collegium Pharmaceutical, Inc. |
Formulaciones de fármacos para la prevención del abuso
|
US20060008432A1
(en)
*
|
2004-07-07 |
2006-01-12 |
Sebastiano Scarampi |
Gilsonite derived pharmaceutical delivery compositions and methods: nail applications
|
ES2362217T3
(es)
*
|
2004-08-03 |
2011-06-29 |
Tepha, Inc. |
Suturas de polihidroxialcanoato no rizadas.
|
JP4745747B2
(ja)
*
|
2004-08-12 |
2011-08-10 |
日東電工株式会社 |
フェンタニル含有貼付製剤
|
JP4824963B2
(ja)
*
|
2004-08-12 |
2011-11-30 |
日東電工株式会社 |
貼付材及び貼付製剤
|
US8252319B2
(en)
*
|
2004-10-21 |
2012-08-28 |
Durect Corporation |
Transdermal delivery system for sufentanil
|
DE602005021909D1
(de)
*
|
2004-10-21 |
2010-07-29 |
Durect Corp |
Transdermale verabreichungssysteme
|
JP2008528204A
(ja)
*
|
2005-01-28 |
2008-07-31 |
テファ, インコーポレイテッド |
ポリ−4−ヒドロキシブチレート粒子を使用した塞栓形成
|
TW200640526A
(en)
*
|
2005-02-24 |
2006-12-01 |
Alza Corp |
Transdermal electrotransport drug delivery systems with reduced abuse potential
|
US7309809B2
(en)
*
|
2005-02-26 |
2007-12-18 |
Xennovate Medical Llc |
Adhesive attachment and removal device
|
US20060223786A1
(en)
*
|
2005-04-01 |
2006-10-05 |
Smith David J |
Transdermal pain control method and device
|
US7740641B2
(en)
*
|
2005-04-14 |
2010-06-22 |
Ethicon Endo-Surgery, Inc. |
Clip applier with migrational resistance features
|
US8038686B2
(en)
*
|
2005-04-14 |
2011-10-18 |
Ethicon Endo-Surgery, Inc. |
Clip applier configured to prevent clip fallout
|
US7261724B2
(en)
|
2005-04-14 |
2007-08-28 |
Ethicon Endo-Surgery, Inc. |
Surgical clip advancement mechanism
|
US7288098B2
(en)
|
2005-04-14 |
2007-10-30 |
Ethicon Endo-Surgery, Inc. |
Force limiting mechanism for medical instrument
|
US8523882B2
(en)
|
2005-04-14 |
2013-09-03 |
Ethicon Endo-Surgery, Inc. |
Clip advancer mechanism with alignment features
|
US7686820B2
(en)
*
|
2005-04-14 |
2010-03-30 |
Ethicon Endo-Surgery, Inc. |
Surgical clip applier ratchet mechanism
|
US7297149B2
(en)
|
2005-04-14 |
2007-11-20 |
Ethicon Endo-Surgery, Inc. |
Surgical clip applier methods
|
EP1895994B1
(fr)
*
|
2005-05-13 |
2010-08-25 |
ALZA Corporation |
Systeme d'administration de medicaments a couches multiples equipe d'une protection contre l'ecoulement de matiere de reservoir
|
WO2006133103A2
(fr)
*
|
2005-06-03 |
2006-12-14 |
Trans-Dermal Patents Company, Llc |
Reservoir pour l'administration d'agents
|
US20090143761A1
(en)
*
|
2005-06-03 |
2009-06-04 |
Transdermal Patents Company, Llc |
Agent delivery system and uses of same
|
US20070098772A1
(en)
*
|
2005-09-23 |
2007-05-03 |
Westcott Tyler D |
Transdermal norelgestromin delivery system
|
EP1937226A2
(fr)
*
|
2005-09-23 |
2008-07-02 |
Alza Corporation |
Systeme d'administration transdermique de galantamine
|
EP1948142B1
(fr)
*
|
2005-09-23 |
2014-04-09 |
ALZA Corporation |
Formulation de polyacrylate superieur avec chargement d'activateur destinee a des applications transdermiques
|
US8852638B2
(en)
|
2005-09-30 |
2014-10-07 |
Durect Corporation |
Sustained release small molecule drug formulation
|
US7888422B2
(en)
*
|
2005-11-09 |
2011-02-15 |
Mylan Technologies Inc. |
Long-wearing removable pressure sensitive adhesive
|
EP1956985A2
(fr)
*
|
2005-11-23 |
2008-08-20 |
Universität Zürich |
Traitement d'une allergie par administration épicutanée d'un allergène
|
EP1986618A2
(fr)
*
|
2006-02-13 |
2008-11-05 |
Aveva Drug Delivery Systems, Inc. |
Preparation adhesive comprenant du sufentanil et ses procedes d'utilisation
|
WO2007121188A2
(fr)
*
|
2006-04-10 |
2007-10-25 |
Knopp Neurosciences, Inc. |
Compositions et procédés d'utilisation de r(+)-pramipexole
|
US8518926B2
(en)
*
|
2006-04-10 |
2013-08-27 |
Knopp Neurosciences, Inc. |
Compositions and methods of using (R)-pramipexole
|
DE102006019293A1
(de)
*
|
2006-04-21 |
2007-10-25 |
LABTEC Gesellschaft für technologische Forschung und Entwicklung mbH |
Pflaster, enthaltend ein Fentanyl Analogum
|
US20070248657A1
(en)
*
|
2006-04-25 |
2007-10-25 |
Smith David J |
Multi-compartment transdermal pain control device
|
ES2641272T3
(es)
|
2006-04-28 |
2017-11-08 |
Children's Hospital Medical Center |
Composiciones que comprenden proteínas o polipéptidos fusogénicos derivados de la prosaposina para aplicación en sistemas de suministro de fármacos transmembrana
|
WO2007137071A2
(fr)
*
|
2006-05-16 |
2007-11-29 |
Knopp Neurosciences, Inc. |
Compositions de r(+) et s(-) pramipéxole et procédés d'utilisation de celles-ci
|
US20070278289A1
(en)
*
|
2006-05-31 |
2007-12-06 |
Toshiba Tec Kabushiki Kaisha |
Payment adjusting apparatus and program therefor
|
MX2008016372A
(es)
*
|
2006-06-19 |
2009-05-28 |
Alpharma Inc |
Composiciones farmaceuticas.
|
US20080009782A1
(en)
*
|
2006-06-28 |
2008-01-10 |
Alza Corporation |
Methods and Devices for Transdermal Electrotransport Delivery of Lofentanil and Carfentanil
|
US20080004671A1
(en)
*
|
2006-06-28 |
2008-01-03 |
Alza Corporation |
Vagus nerve stimulation via orally delivered apparatus
|
KR101486599B1
(ko)
|
2006-07-14 |
2015-01-26 |
히사미쓰 세이야꾸 가부시키가이샤 |
첩부제
|
ES2524556T3
(es)
|
2006-10-09 |
2014-12-10 |
Charleston Laboratories, Inc. |
Composiciones farmacéuticas
|
WO2008066642A2
(fr)
|
2006-11-03 |
2008-06-05 |
Durect Corporation |
Systèmes d'administration par voie transdermique
|
US7943683B2
(en)
*
|
2006-12-01 |
2011-05-17 |
Tepha, Inc. |
Medical devices containing oriented films of poly-4-hydroxybutyrate and copolymers
|
US8524695B2
(en)
*
|
2006-12-14 |
2013-09-03 |
Knopp Neurosciences, Inc. |
Modified release formulations of (6R)-4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine and methods of using the same
|
RU2454409C2
(ru)
|
2007-03-14 |
2012-06-27 |
Нопп Ньюросайенсиз, Инк. |
Синтез хирально очищенных замещенных бензотиазолдиаминов
|
ES2562878T3
(es)
|
2007-05-25 |
2016-03-08 |
Indivior Uk Limited |
Formulaciones de liberación sostenida de compuestos de risperidona
|
AU2008283929B2
(en)
|
2007-08-06 |
2013-10-10 |
Serenity Pharmaceuticals, Llc |
Methods and devices for desmopressin drug delivery
|
US9017301B2
(en)
*
|
2007-09-04 |
2015-04-28 |
Mylan Technologies, Inc. |
Transdermal drug delivery systems comprising a coated release liner
|
MY154027A
(en)
|
2007-10-15 |
2015-04-30 |
Alza Corp |
Once-a-day replacement transdermal administration of fentanyl
|
EP2235171A1
(fr)
*
|
2007-12-12 |
2010-10-06 |
Aarhus Universitet (University Of Aarhus) |
Structure cristalline d'une pompe à protons de la membrane plasmique
|
US20100151014A1
(en)
*
|
2008-12-16 |
2010-06-17 |
Alpharma Pharmaceuticals, Llc |
Pharmaceutical composition
|
US8623418B2
(en)
|
2007-12-17 |
2014-01-07 |
Alpharma Pharmaceuticals Llc |
Pharmaceutical composition
|
ES2620672T3
(es)
|
2008-01-09 |
2017-06-29 |
Charleston Laboratories, Inc. |
Comprimidos de doble capa que comprenden oxicodona y prometazina
|
KR20160027258A
(ko)
*
|
2008-01-28 |
2016-03-09 |
데이고꾸세이약꾸가부시끼가이샤 |
펜타닐 함유 외용 패치
|
EP2111857A1
(fr)
*
|
2008-04-25 |
2009-10-28 |
Acino AG |
Système thérapeutique transdermique destiné à l'application de fentanyle ou d'une matière analogue
|
US11963995B2
(en)
|
2008-05-21 |
2024-04-23 |
Ferring B.V. |
Methods comprising desmopressin
|
US20100286045A1
(en)
|
2008-05-21 |
2010-11-11 |
Bjarke Mirner Klein |
Methods comprising desmopressin
|
ES2756706T3
(es)
*
|
2008-05-21 |
2020-04-27 |
Ferring Bv |
Desmopresina bucodispersable para aumentar el periodo inicial de sueño ininterrumpido por nocturia
|
WO2009140972A2
(fr)
|
2008-05-22 |
2009-11-26 |
H. Lundbeck A/S |
Modulation des récepteurs du domaine vps10p pour le traitement d'une maladie cardiovasculaire
|
US8460657B2
(en)
|
2008-06-25 |
2013-06-11 |
H. Lundbeck A/S |
Modulation of the TrpV: Vps10p receptor system for the treatment of pain
|
JP2011526889A
(ja)
|
2008-06-30 |
2011-10-20 |
アフギン ファーマ,エルエルシー |
局所局部的神経作用療法
|
US20110190356A1
(en)
*
|
2008-08-19 |
2011-08-04 |
Knopp Neurosciences Inc. |
Compositions and Methods of Using (R)- Pramipexole
|
US8637075B2
(en)
|
2008-09-12 |
2014-01-28 |
Pharma Gp Aps |
Colostrum composition
|
US20100221313A1
(en)
*
|
2008-12-01 |
2010-09-02 |
Innovative Pharmaceuticals, Llc |
Transdermal reservoir patch
|
EP3165537A1
(fr)
|
2008-12-19 |
2017-05-10 |
H. Lundbeck A/S |
Modulation de la famille de récepteurs à domaine vps10 pour le traitement de troubles mentaux et du comportement
|
EP2399607B1
(fr)
*
|
2009-02-18 |
2017-11-29 |
Hisamitsu Pharmaceutical Co., Inc. |
Préparation transdermique
|
BRPI1010084A2
(pt)
*
|
2009-06-19 |
2015-08-25 |
Knopp Neurosciences Inc |
Método para tratar esclerose lateral amiotrófica em um paciente
|
EP2451274B1
(fr)
|
2009-07-08 |
2017-10-04 |
Charleston Laboratories, Inc. |
Compositions pharmaceutiques
|
EP2295046B1
(fr)
|
2009-09-14 |
2012-12-19 |
Acino AG |
Système thérapeutique transdermique destiné à l'application de fentanyle ou d'une matière analogue
|
DE102009048973A1
(de)
*
|
2009-10-09 |
2011-04-14 |
Beiersdorf Ag |
Transdermale therapeutische Systeme enthaltend 4-n-Butylresorcin
|
US8262679B2
(en)
|
2009-10-09 |
2012-09-11 |
Ethicon Endo-Surgery, Inc. |
Clip advancer
|
US8267945B2
(en)
|
2009-10-09 |
2012-09-18 |
Ethicon Endo-Surgery, Inc. |
Clip advancer with lockout mechanism
|
US9588121B2
(en)
|
2009-11-06 |
2017-03-07 |
Go Therapeutics, Inc. |
Method for early detection of cancer
|
US10668060B2
(en)
|
2009-12-10 |
2020-06-02 |
Collegium Pharmaceutical, Inc. |
Tamper-resistant pharmaceutical compositions of opioids and other drugs
|
WO2011095174A1
(fr)
|
2010-02-08 |
2011-08-11 |
Aarhus Universitet |
Polypeptides et polynucléotides u20 des virus de l'herpès humain 6 et 7 pour une utilisation en tant que médicament ou diagnostic
|
WO2011107100A1
(fr)
|
2010-03-03 |
2011-09-09 |
Aarhus Universitet |
Procédés et compositions pour la régulation de herv4
|
EP2557924B1
(fr)
|
2010-04-13 |
2019-06-12 |
Relmada Therapeutics, Inc. |
Compositions pharmaceutiques dermiques de 1-méthyl-2',6'-pipécoloxylidide et méthode d'utilisation
|
ES2636673T3
(es)
|
2010-04-28 |
2017-10-06 |
Kimberly-Clark Worldwide, Inc. |
Dispositivo para la administración de medicamentos contra la artritis reumatoide
|
MX2012012567A
(es)
|
2010-04-28 |
2012-11-21 |
Kimberly Clark Co |
Metodo para aumentar la permeabilidad de una barrera epitelial.
|
KR101794376B1
(ko)
|
2010-04-28 |
2017-11-06 |
킴벌리-클라크 월드와이드, 인크. |
siRNA 전달용 의료 기구
|
US9545507B2
(en)
|
2010-04-28 |
2017-01-17 |
Kimberly-Clark Worldwide, Inc. |
Injection molded microneedle array and method for forming the microneedle array
|
CN103339149B
(zh)
|
2010-06-14 |
2016-02-03 |
H.隆德贝克有限公司 |
SorLA和GDNF-家族配体受体之间的相互作用的调节
|
KR101572336B1
(ko)
|
2010-12-22 |
2015-11-26 |
퍼듀 퍼머 엘피 |
케이싱된 탬퍼 저항성 제어 방출 투여 형태
|
AU2011346758C1
(en)
|
2010-12-23 |
2015-09-03 |
Purdue Pharma L.P. |
Tamper resistant solid oral dosage forms
|
WO2012096866A2
(fr)
|
2011-01-10 |
2012-07-19 |
Inverseon, Inc. |
Utilisation d'agonistes inverses beta-adrénergiques pour arrêter de fumer
|
US8696637B2
(en)
|
2011-02-28 |
2014-04-15 |
Kimberly-Clark Worldwide |
Transdermal patch containing microneedles
|
US8428709B1
(en)
|
2012-06-11 |
2013-04-23 |
Incline Therapeutics, Inc. |
Current control for electrotransport drug delivery
|
US8428708B1
(en)
|
2012-05-21 |
2013-04-23 |
Incline Therapeutics, Inc. |
Self-test for analgesic product
|
US8781571B2
(en)
|
2011-03-31 |
2014-07-15 |
Incline Therapeutics, Inc. |
Switch validation circuit and method
|
US9731121B2
(en)
|
2011-03-31 |
2017-08-15 |
Incline Therapeutics, Inc. |
Switch validation circuit and method
|
US20140243765A1
(en)
|
2011-09-22 |
2014-08-28 |
Samyang Biopharmaceuticals Corporation |
Percutaneously absorbable preparation containing fentanyl and homologue thereof
|
CN103764129A
(zh)
|
2011-09-30 |
2014-04-30 |
帝国制药美国公司 |
透皮贴剂处置***
|
RU2014108664A
(ru)
|
2011-09-30 |
2015-11-10 |
ТЕЙКОКУ ФАРМА ЮЭсЭй, ИНК. |
Общая система утилизации лекарственных средств
|
WO2013059432A1
(fr)
|
2011-10-19 |
2013-04-25 |
Ethicon Endo-Surgery, Inc. |
Applicateur d'agrafe conçu pour être utilisé avec un robot chirurgical
|
EP3574950B1
(fr)
|
2011-10-27 |
2021-02-17 |
Sorrento Therapeutics, Inc. |
Administration transdermique d'agents bioactifs à viscosité élevée
|
EP2750690B1
(fr)
|
2011-11-15 |
2018-11-07 |
The Walter and Eliza Hall Institute of Medical Research |
Médiateur soluble
|
EP2599478A1
(fr)
|
2011-11-30 |
2013-06-05 |
Acino AG |
Système thérapeutique transdermique destiné à l'application de fentanyle ou d'une matière analogue
|
US9512096B2
(en)
|
2011-12-22 |
2016-12-06 |
Knopp Biosciences, LLP |
Synthesis of amine substituted 4,5,6,7-tetrahydrobenzothiazole compounds
|
EP2812640B1
(fr)
|
2012-02-10 |
2018-08-08 |
Carrier Corporation |
Procédé de détection de perte de fluide frigorifique
|
JP6279547B2
(ja)
|
2012-04-17 |
2018-02-14 |
パーデュー、ファーマ、リミテッド、パートナーシップ |
オピオイド誘発性有害薬力学的応答を治療するためのシステムおよび方法
|
US20150133383A1
(en)
|
2012-05-11 |
2015-05-14 |
Prorec Bio Ab |
Method for diagnosis and treatment of prolactin associated disorders
|
EP2919759A4
(fr)
|
2012-11-14 |
2016-07-20 |
Ohio State Innovation Foundation |
Matières et procédés utiles pour le traitement du glioblastome
|
WO2014123899A1
(fr)
|
2013-02-05 |
2014-08-14 |
Purdue Pharma L.P. |
Formulations pharmaceutiques inviolables
|
US10729714B2
(en)
|
2013-02-11 |
2020-08-04 |
Glycanova As |
Basidiomycete-derived cream for treatment of skin diseases
|
US9662313B2
(en)
|
2013-02-28 |
2017-05-30 |
Knopp Biosciences Llc |
Compositions and methods for treating amyotrophic lateral sclerosis in responders
|
US20140308352A1
(en)
|
2013-03-11 |
2014-10-16 |
Zogenix Inc. |
Compositions and methods involving polymer, solvent, and high viscosity liquid carrier material
|
CN115804749A
(zh)
|
2013-03-11 |
2023-03-17 |
度瑞公司 |
包含高粘度液体载体的可注射控制释放组合物
|
US10751287B2
(en)
|
2013-03-15 |
2020-08-25 |
Purdue Pharma L.P. |
Tamper resistant pharmaceutical formulations
|
US9682068B2
(en)
|
2013-05-20 |
2017-06-20 |
Mylan Inc. |
Transdermal therapeutic system for extended dosing of pramipexole in treating neurological disorders
|
EP2810646B1
(fr)
|
2013-06-04 |
2016-07-27 |
LTS LOHMANN Therapie-Systeme AG |
Système d'administration transdermique
|
EP3019167B1
(fr)
|
2013-07-12 |
2021-02-17 |
Knopp Biosciences LLC |
Traitement de taux élevés d'éosinophiles et/ou de basophiles
|
US9468630B2
(en)
|
2013-07-12 |
2016-10-18 |
Knopp Biosciences Llc |
Compositions and methods for treating conditions related to increased eosinophils
|
CA2921381A1
(fr)
|
2013-08-13 |
2015-02-19 |
Knopp Biosciences Llc |
Compositions et methodes pour le traitement de l'urticaire chronique
|
CA2921378A1
(fr)
|
2013-08-13 |
2015-02-19 |
Knopp Biosciences Llc |
Compositions et methodes de traitement de troubles des cellules plasmatiques et de troubles prolymphocytaires a cellules b
|
WO2015028027A1
(fr)
|
2013-08-29 |
2015-03-05 |
University Of Copenhagen |
Anticorps anti-adam12 pour le traitement du cancer
|
EP3180040B1
(fr)
|
2014-08-15 |
2020-05-13 |
Tepha, Inc. |
Sutures auto-rétentives de poly-4-hydroxybutyrate et de copolymères de celui-ci
|
US9849124B2
(en)
|
2014-10-17 |
2017-12-26 |
Purdue Pharma L.P. |
Systems and methods for treating an opioid-induced adverse pharmacodynamic response
|
US10626521B2
(en)
|
2014-12-11 |
2020-04-21 |
Tepha, Inc. |
Methods of manufacturing mesh sutures from poly-4-hydroxybutyrate and copolymers thereof
|
CA2969429C
(fr)
|
2014-12-11 |
2020-10-27 |
Tepha, Inc. |
Procedes d'orientation de fil multifilament et de monofilaments de poly-4-hydroxybutyrate et de copolymeres de celui-ci
|
EP3233081B1
(fr)
*
|
2014-12-19 |
2021-09-22 |
Kindeva Drug Delivery L.P. |
Dispositif d'administration transdermique de médicament, comprenant du fentanyl
|
US10905706B2
(en)
|
2015-01-08 |
2021-02-02 |
The Johns Hopkins University |
Compositions and methods to accelerate resolution of acute lung inflammation
|
US10383816B2
(en)
|
2015-03-02 |
2019-08-20 |
Afgin Pharma, Llc |
Topical regional neuro-affective therapy with cannabinoid combination products
|
JP2018507262A
(ja)
|
2015-03-02 |
2018-03-15 |
アフギン ファーマ, エルエルシーAfgin Pharma, Llc |
カンナビノイドを用いた、局所局部的神経作用療法
|
WO2017152130A1
(fr)
|
2016-03-04 |
2017-09-08 |
Charleston Laboratories, Inc. |
Compositions pharmaceutiques
|
WO2017222575A1
(fr)
|
2016-06-23 |
2017-12-28 |
Collegium Pharmaceutical, Inc. |
Procédé de préparation de formulations orales dissuasives d'abus plus stables
|
US20180049994A1
(en)
|
2016-08-16 |
2018-02-22 |
Afgin Pharma, Llc |
Topical regional neuro-affective therapy with caryophyllene
|
US11052054B2
(en)
|
2017-04-19 |
2021-07-06 |
Inep Europe Sarl |
Method for manufacturing a transdermal device
|
US10377114B2
(en)
|
2017-04-20 |
2019-08-13 |
Inep Europe Sarl |
Method for making a transdermal fentanyl patch with even drug crystal distribution
|
US10391065B2
(en)
|
2017-04-19 |
2019-08-27 |
Inep Europe Sarl |
Method for making a transdermal fentanyl patch with even drug crystal distribution
|
US11389844B2
(en)
|
2018-03-20 |
2022-07-19 |
Verde Environmental Technologies, Inc. |
Blister pack disposal system
|
JP6912122B2
(ja)
*
|
2019-02-28 |
2021-07-28 |
日本臓器製薬株式会社 |
経皮投与製剤
|